Long-term comparative outcomes in relapse activity and disability progression among anti-CD20 therapies in relapsing multiple sclerosis: An unanchored matching-adjusted indirect comparison.
Gold R, Ansaripour A, Schmierer K, Barnett M, Hartung H P, Yamout B, de Seze J, Selmaj K, Centonze D, Grigoriadis N, et al.
Mult Scler Relat Disord. 2026 Sep 30; 115:107953. PMID: 42832972.Abstract
